Hammarström Per, Jiang Xin, Hurshman Amy R, Powers Evan T, Kelly Jeffery W
Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road BCC265, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4(Suppl 4):16427-32. doi: 10.1073/pnas.202495199. Epub 2002 Sep 25.
Several misfolding diseases commence when a secreted folded protein encounters a partially denaturing microenvironment, enabling its self assembly into amyloid. Although amyloidosis is modulated by numerous environmental and genetic factors, single point mutations within the amyloidogenic protein can dramatically influence disease phenotype. Mutations that destabilize the native state predispose an individual to disease; however, thermodynamic stability alone does not reliably predict disease severity. Here we show that the rate of transthyretin (TTR) tetramer dissociation required for amyloid formation is strongly influenced by mutation (V30M, L55P, T119M, V122I), with rapid rates exacerbating and slow rates reducing amyloidogenicity. Although these rates are difficult to predict a priori, they notably influence disease penetrance and age of onset. L55P TTR exhibits severe pathology because the tetramer both dissociates quickly and is highly destabilized. Even though V30M and L55P TTR are similarly destabilized, the V30M disease phenotype is milder because V30M dissociates more slowly, even slower than wild type (WT). Although WT and V122I TTR have nearly equivalent tetramer stabilities, V122I cardiomyopathy, unlike WT cardiomyopathy, has nearly complete penetrance-presumably because of its 2-fold increase in dissociation rate. We show that the T119M homotetramer exhibits kinetic stabilization and therefore dissociates exceedingly slowly, likely explaining how it functions to protect V30MT119M compound heterozygotes from disease. An understanding of how mutations influence both the kinetics and thermodynamics of misfolding allows us to rationalize the phenotypic diversity of amyloid diseases, especially when considered in concert with other genetic and environmental data.
当一种分泌型折叠蛋白遇到部分变性的微环境时,几种错误折叠疾病就会开始,使其能够自组装成淀粉样蛋白。尽管淀粉样变性受多种环境和遗传因素调节,但淀粉样蛋白生成蛋白内的单点突变可显著影响疾病表型。使天然状态不稳定的突变使个体易患疾病;然而,仅热力学稳定性并不能可靠地预测疾病严重程度。在这里,我们表明,转甲状腺素蛋白(TTR)四聚体解离速率对淀粉样蛋白形成所需的速率受突变(V30M、L55P、T119M、V122I)的强烈影响,快速速率会加剧淀粉样蛋白生成,而缓慢速率则会降低淀粉样蛋白生成能力。尽管这些速率很难先验预测,但它们显著影响疾病的外显率和发病年龄。L55P TTR表现出严重的病理学特征,因为四聚体既快速解离又高度不稳定。尽管V30M和L55P TTR同样不稳定,但V30M疾病表型较轻,因为V30M解离更慢,甚至比野生型(WT)还慢。尽管WT和V122I TTR具有几乎相同的四聚体稳定性,但与WT心肌病不同,V122I心肌病几乎具有完全的外显率——可能是因为其解离速率增加了2倍。我们表明,T119M同型四聚体表现出动力学稳定,因此解离极其缓慢,这可能解释了它如何保护V30MT119M复合杂合子免受疾病影响。了解突变如何影响错误折叠的动力学和热力学,使我们能够合理化淀粉样疾病的表型多样性,特别是当与其他遗传和环境数据一起考虑时。